Hackensack, NJ – (January 26, 2012) – Mark your calendars, the Breast Cancer Division of the John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's top 50 cancer centers, will recap and explain research from the 2011 San Antonio Breast Cancer Symposium on Friday, February 17 from 7:00 am to 3:00 pm during its ninth annual Northern New Jersey Breast Cancer Conference.
The San Antonio Breast Cancer Symposium is recognized internationally as one of the most important research conferences for breast cancer. This year's event focused on emerging treatments in hard-to-treat populations, including patients with metastatic breast cancer, and on new knowledge about prevention and risk.
"We are constantly searching for the latest treatments and therapies to help our patients beat cancer, " said Stanley Waintraub, M.D., Co-Chief, Breast Oncology, John Theurer Cancer Center. "Part of that includes understanding the most recent developments in clinical oncology. We are excited to share and explain what this year's San Antonio conference means for health care professionals and patients."
The objective of the ninth annual Northern New Jersey Breast Cancer Conference is to provide the New Jersey medical community with practical information on experimental biology, etiology, prevention, diagnosis and therapy of breast cancer/premalignant breast disease. Physicians and researchers involved in medical surgery, GYN and radiation therapy, as well as other appropriate health care professionals are encouraged to attend.
Attendees will learn about new therapies available in breast cancer, patients who will benefit from the new treatments in advanced/metastatic disease, and new combination therapies for metastatic disease. The agenda includes renowned speakers from some of the best cancer centers in the country, including:
"Extraordinary care means providing the very best and latest in research and innovation, ensuring for our patients that they will receive cutting edge, world-class cancer care," said Andrew L Pecora, M.D., F.A.C.P., C.P.E, Chief Innovations Officer, Professor, and Vice President of Cancer Services. "We are pleased to be hosting the ninth annual Northern New Jersey Breast Cancer Conference in 2012."
This educational activity is designated for a maximum of 6.0 AMA PRA Category 1 Credits. Registration is free and includes a complimentary, continental breakfast and lunch. To RSVP, please contact Bonnie LoGiudice at 201-996-4891 or blogiudice@hackensackUMC.org.
About the John Theurer Cancer Center at Hackensack University Medical Center
John Theurer Cancer Center at Hackensack University Medical Center is among the nation's top 50 U.S. News and World Report Best Hospitals for cancer – the only cancer center in New Jersey with this designation. It is New Jersey's largest and most comprehensive cancer center dedicated to the diagnosis, treatment, management, research, screenings, preventive care, as well as survivorship of patients with all types of cancer.
Each year, more people in the New Jersey/New York metropolitan area turn to the John Theurer Cancer Center for cancer care than to any other facility in New Jersey. The 14 specialized divisions feature a team of medical, research, nursing, and support staff with specialized expertise that translates into more advanced, focused care for all patients. The John Theurer Cancer Center provides comprehensive multidisciplinary care, state of the art technology, access to clinical trials, compassionate care and medical expertise—all under one roof. For more information please visit jtcancercenter.org.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.